베노바이오
top of page

History

twi001t3294713 (1).jpg

2021

  • Completed lead compound screening for Osteoarthritis therapy

  • Conduct the GLP toxicity studies for AMD therapeutic drug

2020

  • Completed lead compound screening as KRAS inhibitor

  • Completed lead compound screening for AMD therapy

  • Completed lead compound screening for Anti-Cancer drug

  • Completed lead compound screening for therapeutic agent in Covid-19

  • Patents application for drug substance and method of use

tc00480000878.jpg
twi001t3126689.jpg

2019

  • Patent application of novel active compounds

  • Completed active compound screening as BET inhibitors

2018

  • BenoBio Co., Ltd. Established (AUG. 2018)

  • Completed lead compound screening as epigenetic regulators

graphic-design-and-color-swatches-and-pens-on-a-desk-architectural-drawing-with-work-tools
bottom of page